- Previous Close
3,600.00 - Open
3,550.00 - Bid 3,565.00 x --
- Ask 3,575.00 x --
- Day's Range
3,475.00 - 3,620.00 - 52 Week Range
3,350.00 - 7,110.00 - Volume
81,990 - Avg. Volume
144,249 - Market Cap (intraday)
113.285B - Beta (5Y Monthly) 0.64
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield 100.00 (2.68%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
--
iNtRON Biotechnology, Inc. engages in the development of novel drugs in South Korea. It develops bacteriophage and endolysin based drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
www.intron.co.krRecent News: 048530.KQ
View MorePerformance Overview: 048530.KQ
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 048530.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 048530.KQ
View MoreValuation Measures
Market Cap
114.08B
Enterprise Value
65.55B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
18.40
Price/Book (mrq)
1.36
Enterprise Value/Revenue
10.21
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-40.37%
Return on Assets (ttm)
-3.54%
Return on Equity (ttm)
-2.87%
Revenue (ttm)
6.42B
Net Income Avi to Common (ttm)
-2.59B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
49.78B
Total Debt/Equity (mrq)
1.49%
Levered Free Cash Flow (ttm)
-562.47M